1. Allergan withdraws ulipristal from Canada due to serious liver injury

   News item 17 October 2020 Pages: 1 - 1

2. Bupropion may increase risk of psoriasis exacerbation

   News item 17 October 2020 Pages: 2 - 2

3. FDA's CDER proposes market withdrawal of hydroxyprogesterone

   News item 17 October 2020 Pages: 3 - 3

4. PMDA recommends package insert revisions for five products

   News item 17 October 2020 Pages: 4 - 4

5. Remdesivir-related acute kidney injury in patients with COVID-19

   News item 17 October 2020 Pages: 5 - 5

6. Additional risk minimisation measures for medicines approved in the EU

   Clinical study 17 October 2020 Pages: 6 - 6

7. Antipsychotic augmentation for adult depression: excess mortality risk

   Clinical study 17 October 2020 Pages: 7 - 7

8. Increases in youth suicide deaths after FDA antidepressant warnings

   Clinical study 17 October 2020 Pages: 8 - 8

9. Risk of neuroleptic malignant syndrome with recent antipsychotic use

   Clinical study 17 October 2020 Pages: 9 - 9

10. Statin-related AEs reported on Twitter support regulatory data

    Clinical study 17 October 2020 Pages: 10 - 10

11. Other adverse reaction research

    News item 17 October 2020 Pages: 11 - 11

12. Abatacept/etanercept/tocilizumab

    Case report 17 October 2020 Pages: 12 - 12

13. Abatacept/sirolimus/tacrolimus

    Case report 17 October 2020 Pages: 13 - 13

14. Acetazolamide

    Case report 17 October 2020 Pages: 14 - 14

15. Aciclovir

    Case report 17 October 2020 Pages: 15 - 15

16. Aciclovir

    Case report 17 October 2020 Pages: 16 - 16

17. Adalimumab

    Case report 17 October 2020 Pages: 17 - 17

18. Adalimumab

    Case report 17 October 2020 Pages: 18 - 18

19. Adalimumab/certolizumab-pegol

    Case report 17 October 2020 Pages: 19 - 19

20. Adalimumab/certolizumab-pegol

    Case report 17 October 2020 Pages: 20 - 20

21. Adalimumab/methotrexate

    Case report 17 October 2020 Pages: 21 - 21

22. Adalimumab/methotrexate

    Case report 17 October 2020 Pages: 22 - 22

23. Afatinib

    Case report 17 October 2020 Pages: 23 - 23

24. Afatinib/icotinib

    Case report 17 October 2020 Pages: 24 - 24

25. Aflibercept/bevacizumab

    Case report 17 October 2020 Pages: 25 - 25

26. Alectinib

    Case report 17 October 2020 Pages: 26 - 26

27. Alemtuzumab

    Case report 17 October 2020 Pages: 27 - 27

28. Alemtuzumab/antibacterials/immunosuppressants

    Case report 17 October 2020 Pages: 28 - 28

29. Alendronic acid

    Case report 17 October 2020 Pages: 29 - 29

30. Alfentanil

    Case report 17 October 2020 Pages: 30 - 30

31. Amikacin/ampicillin/cefotaxime

    Case report 17 October 2020 Pages: 31 - 31

32. Amiodarone/dobutamine

    Case report 17 October 2020 Pages: 32 - 32

33. Amiodarone/prednisone/thiamazole

    Case report 17 October 2020 Pages: 33 - 33

34. Amlodipine

    Case report 17 October 2020 Pages: 34 - 34

35. Amlodipine/atenolol overdose

    Case report 17 October 2020 Pages: 35 - 35

36. Amoxicillin/lamotrigine

    Case report 17 October 2020 Pages: 36 - 36

37. Amphotericin-b/dexamethasone/tocilizumab

    Case report 17 October 2020 Pages: 37 - 37

38. Ampicillin/meropenem/vancomycin

    Case report 17 October 2020 Pages: 38 - 38

39. Antibacterials

    Case report 17 October 2020 Pages: 39 - 39

40. Antibacterials/antivirals

    Case report 17 October 2020 Pages: 40 - 40

41. Antibacterials/cyclophosphamide

    Case report 17 October 2020 Pages: 41 - 41

42. Antibiotics

    Case report 17 October 2020 Pages: 42 - 42

43. Anticoagulants/aspirin

    Case report 17 October 2020 Pages: 43 - 43

44. Anticoagulants/ibrutinib

    Case report 17 October 2020 Pages: 44 - 44

45. Antiepileptic-drugs

    Case report 17 October 2020 Pages: 45 - 45

46. Antiepileptics

    Case report 17 October 2020 Pages: 46 - 46

47. Antifungals/antiretrovirals

    Case report 17 October 2020 Pages: 47 - 47

48. Antineoplastics

    Case report 17 October 2020 Pages: 48 - 48

49. Antineoplastics

    Case report 17 October 2020 Pages: 49 - 49

50. Antineoplastics

    Case report 17 October 2020 Pages: 50 - 50